Skip to main content
Frederick G. Welt
( out of 102 reviews )

Frederick G. Welt, MD

Languages spoken: English

Clinical Locations

Stansbury Health Center

Tooele
435-843-3000

University of Utah Hospital

Cardiovascular Center
Salt Lake City
801-585-7676
  • Frederick Welt, M.D. is Associate Chief of Cardiovascular Medicine at the University of Utah School of Medicine and Director of the Cardiac Catheterization Laboratory. He is a professor of medicine and member of the Interventional Cardiology faculty.

    Dr. Welt most recently served as the Director of Interventional Cardiology at Brigham and Women's Hospital in Boston, as well as Director of the Interventional Cardiovascular Experimental Laboratory. His clinical practice included outpatient clinical care and performing diagnostic catheterizations and coronary interventions.

    Dr. Welt specializes in both interventional coronary and structural heart disease cases including Trans Catheter Aortic Valve Replacement (TAVR). His clinical responsibilities include invasive management of acute heart attacks and assessment of valvular heart disease, coronary stent implantation/balloon angioplasty and PFO/ASD closure.

    He is also an active clinical investigator, having been involved in the PARTNER trial of transcatheter aortic valve replacement devices, translational research of novel devices to treat structural heart disease and protocols involving stem cell therapy for cardiac disease.

    Dr. Welt graduated from the Yale University School of Medicine in 1992, and completed residency and fellowship at the Brigham and Women's Hospital in Boston. He also served as Chief Resident at the West Roxbury VA Hospital and completed a research fellowship at Harvard Medical School. In addition to practicing and teaching at BWH and Harvard he has written numerous journal articles as well as serving as a reviewer for publications.

    Board Certification

    American Board of Internal Medicine (Sub: Cardiovascular Disease)
    American Board of Internal Medicine (Sub: Interventional Cardiology)

    Patient Rating

    4.9 /5
    ( out of 102 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    April 26, 2024
    UH HOSPITALS AND CLINICS

    Good Doctor cares about his patients does the best for them.

    April 24, 2024
    UNIVERSITY HOSPITAL

    Dr. Welt is always so calm and reassuring. His explanations are thorough and easy to follow. I have every confidence in him and his team.

    March 27, 2024
    UH HOSPITALS AND CLINICS

    Very personable and extremely professional!!!

    March 20, 2024
    UNIVERSITY HOSPITAL

    Dr. Welt was kind, thorough, thoughtful and clearly committed to providing exceptional care.

    March 10, 2024
    UH HOSPITALS AND CLINICS

    Dr. Welt took the time to listen to me, discuss my medical issues, and included my input in his plan for care moving forward.

    March 01, 2024
    UH HOSPITALS AND CLINICS

    Compassionate and knowledgeable Cardiologist. This is a person you want on your medical team.

    February 28, 2024
    UH HOSPITALS AND CLINICS

    If you want the BEST, then Dr Welt is the cardiologist for you.

    February 13, 2024
    EXTERNAL SITE

    Seems like a very good Dr. and took time to ensure that I understood my condition.

    January 31, 2024
    UH HOSPITALS AND CLINICS

    An excellent knowledgeable person answered all concerns

  • Frederick Welt, M.D. is Associate Chief of Cardiovascular Medicine at the University of Utah School of Medicine and Director of the Cardiac Catheterization Laboratory. He is a professor of medicine and member of the Interventional Cardiology faculty.

    Dr. Welt most recently served as the Director of Interventional Cardiology at Brigham and Women's Hospital in Boston, as well as Director of the Interventional Cardiovascular Experimental Laboratory. His clinical practice included outpatient clinical care and performing diagnostic catheterizations and coronary interventions.

    Dr. Welt specializes in both interventional coronary and structural heart disease cases including Trans Catheter Aortic Valve Replacement (TAVR). His clinical responsibilities include invasive management of acute heart attacks and assessment of valvular heart disease, coronary stent implantation/balloon angioplasty and PFO/ASD closure.

    He is also an active clinical investigator, having been involved in the PARTNER trial of transcatheter aortic valve replacement devices, translational research of novel devices to treat structural heart disease and protocols involving stem cell therapy for cardiac disease.

    Dr. Welt graduated from the Yale University School of Medicine in 1992, and completed residency and fellowship at the Brigham and Women's Hospital in Boston. He also served as Chief Resident at the West Roxbury VA Hospital and completed a research fellowship at Harvard Medical School. In addition to practicing and teaching at BWH and Harvard he has written numerous journal articles as well as serving as a reviewer for publications.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Cardiovascular Medicine
    Board Certification
    American Board of Internal Medicine (Sub: Cardiovascular Disease)
    American Board of Internal Medicine (Sub: Interventional Cardiology)

    Education history

    Graduate Training Medical Sciences - Harvard University M.S.
    Clinical Investigator Training Program - Harvard Medical School, Massachusetts Institute of Technology Research Fellow
    Fellowship Interventional Cardiology - Brigham and Women’s Hospital Fellow
    Cardiovascular Medicine - Brigham and Women’s Hospital Clinical Fellow
    Chief Resident Internal Medicine - West Roxbury VA Hospital Chief Resident
    Cardiology - South Shore Hospital Fellow
    Residency Internal Medicine - Brigham and Women’s Hospital Senior Assistant Resident
    Internal Medicine - Brigham and Women’s Hospital Junior Assistant Resident
    Professional Medical Medicine - Yale University School of Medicine M.D.
    Earth and Mineral Sciences - Pennsylvania State University Research Fellow
    Undergraduate Geology - Duke University B.S.

    Selected Publications

    Journal Article

    1. Naidu SS, Abbott JD, Bagai J, Blankenship J, Garcia S, Iqbal SN, Kaul P, Khuddus MA, Kirkwood L, Manoukian SV, Patel MR, Skelding K, Slotwiner D, Swaminathan RV, Welt FG, Kolansky DM (2021). SCAI expert consensus update on best practices in the cardiac catheterization laboratory: This statement was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), and the Heart Rhythm Society (HRS) in April 2021. Catheter Cardiovasc Interv, 98(2), 255-276. (Read full article)
    2. Kleiman NS, Welt FGP, Truesdell AG, Sherwood M, Kadavath S, Shah PB, Klein LW, Hogan S, Kavinsky C, Rab T, Interventional Section Leadership Council American College of Cardiology (2020). Should Interventional Cardiologists Super-Subspecialize?: Moving From Patient Selection to Operator Selection. JACC Cardiovasc Interv, 14(1), 97-100. (Read full article)
    3. Tandar A, Sharma V, Ibrahim M, Jones T, Morgan D, Montzingo C, Lee J, Birgenheier N, Silverton N, Abraham A, Welt FGP, Glotzbach JP (2021). Preventing or Minimizing Acute Kidney Injury in Patients Undergoing Transcatheter Aortic Valve Replacement. J Invasive Cardiol, 33(1), E32-E39. (Read full article)
    4. Yong CM, Ang L, Welt FGP, Gummidipundi S, Henry TD, Pinto DS, Cox D, Wang P, Asch S, Mahmud E, Fearon WF, Society for Cardiovascular Angiography and Interventions SCAI and the American College of Cardiology ACC Interventional Council (2020). Cardiac procedural deferral during the coronavirus (COVID-19) pandemic. Catheter Cardiovasc Interv, 96(5), 1080-1086. (Read full article)
    5. Jones TL, Golomb M, Dranow E, Welt FGP, Shah PB (2020). The case for a qualitative lesion assessment system for coronary angiography. Catheter Cardiovasc Interv, 98(3), 520-525. (Read full article)
    6. Shah PB, Welt FGP, Mahmud E, Phillips A, Kleiman NS, Young MN, Sherwood M, Batchelor W, Wang DD, Davidson L, Wyman J, Kadavath S, Szerlip M, Hermiller J, Fullerton D, Anwaruddin S (2020). Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: An ACC/SCAI position statement. Catheter Cardiovasc Interv, 96(3), 659-663. (Read full article)
    7. Mahmud E, Dauerman HL, Welt FGP, Messenger JC, Rao SV, Grines C, Mattu A, Kirtane AJ, Jauhar R, Meraj P, Rokos IC, Rumsfeld JS, Henry TD (2020). Management of acute myocardial infarction during the COVID-19 pandemic: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP). Catheter Cardiovasc Interv, 96(2), 336-345. (Read full article)
    8. Jones TL, Gowani SA, Abraham A, Sharma V, Glotzbach J, Morgan D, Welt FGP, Tandar A (2020). Trans-septal puncture through Gore® Cardioform Septal Occluder device - Step by step approach. Cardiovasc Revasc Med, 23, 91-93. (Read full article)
    9. Welt FGP, Shah PB, Aronow HD, Bortnick AE, Henry TD, Sherwood MW, Young MN, Davidson LJ, Kadavath S, Mahmud E, Kirtane AJ, American College of Cardiologys Interventional Council and the Society for Cardiovascular Angiography and Interventions (2020). Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC's Interventional Council and SCAI. J Am Coll Cardiol, 75(18), 2372-2375. (Read full article)
    10. Tonna JE, McKellar SH, Selzman CH, Drakos S, Koliopoulou AG, Taleb I, Stoddard GJ, Stehlik J, Welt FGP, Fair JF 3rd, Stoddard K, Youngquist ST (2020). Exploratory analysis of myocardial function after extracorporeal cardiopulmonary resuscitation vs conventional cardiopulmonary resuscitation. BMC Res Notes, 13(1), 137. (Read full article)
    11. Welt FGP, Fang JC (2019). Pressure Volume System for Management of Heart Failure and Valvular Heart Disease. Curr Cardiol Rep, 21(12), 153. (Read full article)
    12. Fisher JD, Welt FG, Villines TC, Truesdell AG, Young MN, Lakkireddy D, Lee BK, ACCs Electrophysiology Section Leadership Council, ACCs Interventional Section Leadership Council, ACCs Imaging Section Leadership Council (2019). Impact of New Guidelines of Unscheduled and Scheduled Sedation for Cardiologists: JACC Council Perspectives. J Am Coll Cardiol, 74(11), 1505-1511. (Read full article)
    13. Klein LW, Rab T, Anderson HV, Lotfi A, Truesdell AG, Duffy PL, Welt F, Mehran R, Kleiman NS, Workgroup on Acute Care Cardiology and the Interventional Section Leadership Council, American College of Cardiology (2018). The Implications of Acute Clinical Care Responsibilities on the Contemporary Practice of Interventional Cardiology. JACC Cardiovasc Interv, 12(6), 595-599. (Read full article)
    14. Sardar P, Enakpene E, Fang JC, Welt FGP (2017). Acute Coronary Syndrome Resulting From Systolic Compression of Left Main Coronary Artery Secondary to Aortic Subvalvular Aneurysm. JACC Cardiovasc Interv, 10(7), e69-e70. (Read full article)
    15. Sunkara N, Tandar A, Patel AN, Martin MH, Welt FG (2017). Use of a Palmaz Intrahepatic Stent for Fixation of a CoreValve During Treatment of Native Aortic Valve Regurgitation. J Struct Heart Dis, 3(1), 28-34.
    16. Tandar A, Bull DA, Welt FG (2017). Bioprosthetic Aortic Paravalvular Leak: Is Valve-in-Valve Another Solution? J Invasive Cardiol, 29(1), E1-E7. (Read full article)
    17. Pasala T, Gajulapalli RD, Bolen S, Bajaj NS, Gandhi S, Tandar A, Owan T, Welt FG (2016). Transradial access mitigates bleeding benefit offered by bivalirudin over heparin in patients undergoing percutaneous coronary intervention: Insights from meta-analysis of randomized and observational studies. Int J Cardiol, 221, 601-8. (Read full article)
    18. McCabe JM, Huang PH, Cohen DJ, Blackstone EH, Welt FGP, Davidson MJ, Kaneko T, Eng MH, Allen KB, Xu K, Lowry AM, Lei Y, Rajeswaran J, Brown DL, Mack MJ, Webb JG, Smith CR, Leon MB, Eisenhauer AC, PARTNER Trial Investigators (2016). Surgical Versus Percutaneous Femoral Access for Delivery of Large-Bore Cardiovascular Devices (from the PARTNER Trial). Am J Cardiol, 117(10), 1643-1650. (Read full article)
    19. Ravindra VM, Mazur MD, Kumpati GS, Park MS, Patel AN, Tandar A, Welt FG, Bull D, Couldwell WT, Taussky P (2016). Carotid Artery Stenosis in the Setting of Transcatheter Aortic Valve Replacement: Clinical and Technical Considerations of Carotid Stenting. World Neurosurg, 86, 194-8. (Read full article)
    20. Lindley EM, Hall AK, Hess J, Abraham J, Smith B, Hopkins PN, Shihab F, Welt F, Owan T, Fang JC (2016). Cardiovascular Risk Assessment and Management in Prerenal Transplantation Candidates. Am J Cardiol, 117(1), 146-50. (Read full article)
    21. Rossi JE, Noll A, Bergmark B, McCabe JM, Nemer D, Okada DR, Vasudevan A, Davidson M, Welt F, Eisenhauer A, Shah P, Giugliano R (2015). Variability in Antithrombotic Therapy Regimens Peri-TAVR: A Single Academic Center Experience. Cardiol Ther, 4(2), 197-201. (Read full article)
    22. Bangalore S, Silbaugh TS, Normand SL, Lovett AF, Welt FG, Resnic FS (2015). Drug-eluting stents versus bare metal stents prior to noncardiac surgery. Catheter Cardiovasc Interv, 85(4), 533-41. (Read full article)
    23. McCabe JM, Huang PH, Riedl LA, Devireddy SR, Grondell J, Connors AC, Davidson MJ, Eisenhauer AC, Welt FG (2014). Incidence and implications of idiopathic thrombocytopenia following transcatheter aortic valve replacement with the Edwards Sapien((c)) valves: A single center experience. Catheter Cardiovasc Interv, 83(4), 633-41. (Read full article)
    24. McCabe JM, Joynt KE, Welt FG, Resnic FS (2013). Impact of public reporting and outlier status identification on percutaneous coronary intervention case selection in Massachusetts. JACC Cardiovasc Interv, 6(6), 625-30. (Read full article)
    25. Welt FG, Gallegos R, Connell J, Kajstura J, DAmario D, Kwong RY, Coelho-Filho O, Shah R, Mitchell R, Leri A, Foley L, Anversa P, Pfeffer MA (2013). Effect of cardiac stem cells on left-ventricular remodeling in a canine model of chronic myocardial infarction. Circ Heart Fail, 6(1), 99-106. (Read full article)
    26. DAmario D, Fiorini C, Campbell PM, Goichberg P, Sanada F, Zheng H, Hosoda T, Rota M, Connell JM, Gallegos RP, Welt FG, Givertz MM, Mitchell RN, Leri A, Kajstura J, Pfeffer MA, Anversa P (2011). Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res, 108(7), 857-61. (Read full article)
    27. Rybicki FJ, Melchionn S, Mitsouras D, Coskun AU, Whitmore AG, Steigner M, Nallamshetty L, Welt FG, Bernaschi M, Borkin M, Sircar J, Kaxiras E, Succi S, Stone PH, Feldman CL (2009). Prediction of coronary artery plaque progression and potential rupture from 320-detector row prospectively ECG-gated single heart beat CT angiography: Lattice Boltzmann evaluation of endothelial shear stress. Int J Cardiovasc Imaging, 25, 289-99.
    28. Tahir SM, Price LL, Shah PB, Welt FG (2008). Eighteen year (1985-2002) analysis of incidence, mortality, and cardiac procedure outcomes of acute myocardial infarction in patients > or = 65 years of age. Am J Cardiol, 101(7), 930-6. (Read full article)
    29. Losordo DW, Schatz RA, White CJ, Udelson JE, Veereshwarayya V, Durgin M, Poh KK, Weinstein R, Kearney M, Chaudhry M, Burg A, Eaton L, Heyd L, Thorne T, Shturman L, Hoffmeister P, Story K, Zak V, Dowling D, Traverse JH, Olson RE, Flanagan J, Sodano D, Murayama T, Kawamoto A, Kusano KF, Wollins J, Welt F, Shah P, Soukas P, Asahara T, Henry TD (2007). Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation, 115(25), 3165-72. (Read full article)
    30. Welt FG, Rogers SD, Zhang X, Ehlers R, Chen Z, Nannizzi-Alaimo L, Phillips DR, Simon DI (2004). GP IIb/IIIa inhibition with eptifibatide lowers levels of soluble CD40L and RANTES after percutaneous coronary intervention. Catheter Cardiovasc Interv, 61(2), 185-9. (Read full article)
    31. Welt FG, Tso C, Edelman ER, Kjelsberg MA, Paolini JF, Seifert P, Rogers C (2003). Leukocyte recruitment and expression of chemokines following different forms of vascular injury. Vasc Med, 8(1), 1-7. (Read full article)
    32. Sedlis SP, Morrison DA, Lorin JD, Esposito R, Sethi G, Sacks J, Henderson W, Grover F, Ramanathan KB, Weiman D, Saucedo J, Antakli T, Paramesh V, Pett S, Vernon S, Birjiniuk V, Welt F, Krucoff M, Wolfe W, Lucke JC, Mediratta S, Booth D, Murphy E, Ward H, Miller L, Kiesz S, Barbiere C, Lewis D (2002). Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry. J Am Coll Cardiol, 40(9), 1555-66. (Read full article)
    33. Sharma GV, Woods PA, Lambrew CT, Berg CM, Pietro DA, Rocco TP, Welt F, Sacchetti P, McIntyre KM (2002). Evaluation of a noninvasive system for determining left ventricular filling pressure. Arch Intern Med, 162(18), 2084-8. (Read full article)
    34. Danenberg HD, Welt FG, Walker M 3rd, Seifert P, Toegel GS, Edelman ER (2002). Systemic inflammation induced by lipopolysaccharide increases neointimal formation after balloon and stent injury in rabbits. Circulation, 105(24), 2917-22. (Read full article)
    35. Horvath C, Welt FG, Nedelman M, Rao P, Rogers C (2002). Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted. Circ Res, 90(4), 488-94. (Read full article)
    36. Morrison DA, Sethi G, Sacks J, Henderson W, Grover F, Sedlis S, Esposito R, Ramanathan KB, Weiman D, Talley JD, Saucedo J, Antakli T, Paramesh V, Pett S, Vernon S, Birjiniuk V, Welt F, Krucoff M, Wolfe W, Lucke JC, Mediratta S, Booth D, Barbiere C, Lewis D (2002). Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trial. J Am Coll Cardiol, 39(2), 266-73. (Read full article)
    37. Welt FG, Woods TC, Edelman ER (2001). Oral heparin prevents neointimal hyperplasia after arterial injury: inhibitory potential depends on type of vascular injury. Circulation, 104(25), 3121-4. (Read full article)
    38. Morrison DA, Sethi G, Sacks J, Henderson W, Grover F, Sedlis S, Esposito R, Ramanathan K, Weiman D, Saucedo J, Antakli T, Paramesh V, Pett S, Vernon S, Birjiniuk V, Welt F, Krucoff M, Wolfe W, Lucke JC, Mediratta S, Booth D, Barbiere C, Lewis D (2001). Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). J Am Coll Cardiol, 38(1), 143-9. (Read full article)
    39. Welt FG, Edelman ER, Simon DI, Rogers C (2000). Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries. Arterioscler Thromb Vasc Biol, 20(12), 2553-8. (Read full article)
    40. Wang SY, Welt FG, Rutlen DL (1998). Severe haemorrhage partially reverses moderate haemorrhage-induced decrease in intestinal vascular capacitance. Acta Physiol Scand, 162(1), 1-8. (Read full article)
    41. Rogers C, Welt FG, Karnovsky MJ, Edelman ER (1996). Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin. Arterioscler Thromb Vasc Biol, 16(10), 1312-8. (Read full article)
    42. Rutlen DL, Welt FG, Ilebekk A (1992). Passive effect of reduced cardiac function on splanchnic intravascular volume. Am J Physiol, 262(5 Pt 2), H1361-4. (Read full article)
    43. Welt FG, Rutlen DL (1991). Effect of vasopressin on systemic capacity. Am J Physiol, 261(5 Pt 2), H1494-8. (Read full article)
    44. McCaffrey TA, Falcone DJ, Brayton CF, Agarwal LA, Welt FG, Weksler BB (1989). Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex. J Cell Biol, 109(1), 441-8. (Read full article)
    45. Eggler DH, Meen JK, Welt F, Dudas FO, Furlong KP, McCallum ME, Carlson RW (1988). Tectonomagmatism of the Wyoming Province. 83, 25-0.

    Review

    1. Vallabhajosyula S, Kadavath S, Truesdell AG, Young MN, Batchelor WB, Welt FG, Kirtane AJ, Bortnick AE, ACC Interventional Section Leadership Council (2022). It Is Time for Interventional Cardiology Fellowship to Join the National Resident Matching Program. [Review]. JACC Cardiovasc Interv, 15(17), 1762-1767. (Read full article)

    Book Chapter

    1. Welt FG, Moreno PR (2019). Chapter 1 - Vascular Biology. In Mukherjee D, Lange RA, Chatterjee S, Cho L, Moliterno DJ (Eds.), Interventional Cardiology 1133 Questions: An Interventional Cardiology Board Review (Third Edition, pp. 1-11). Wolters Kluwer.
    2. Welt FGP, Simon D (2018). Pathobiology of Vascular Disease: Fundamentals of Atherosclerosis. In Moliterno D, Dehmer G, Kandzari D, Rao S, Ziada K (Eds.), CathSap Cardiac Catheterization & Interventional Cardiology Self-Assessment Program (Version 4).

    Case Report

    1. Jones TL, Sharma V, Glotzbach JP, Welt FGP, Tandar A (2020). Is timing everything? Bioprosthetic valve fracture in valve-in-valve TAVR. J Card Surg, 35(11), 3242-3243. (Read full article)

    Editorial

    1. Welt FGP (2019). Atrial Fibrillation, Diabetes, and Percutaneous Coronary Intervention: A Complicated Triad. JACC Cardiovasc Interv, 12(23), 2356-2358. (Read full article)

    Letter

    1. Taleb I, Koliopoulou AG, Tandar A, McKellar SH, Tonna JE, Nativi-Nicolau J, Alvarez Villela M, Welt F, Stehlik J, Gilbert EM, Wever-Pinzon O, Morshedzadeh JH, Dranow E, Selzman CH, Fang JC, Drakos SG (2019). Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support: A Proof of Concept. [Letter to the editor]. Circulation, 140(1), 98-100. (Read full article)

    Abstract

    1. Patel J, Fearon W, Elmariah S, Kim J, Kapadia S, Kumbhani D, Gillam L, Whisenant B, Quader N, Welt FG, Maniar H, Bavry A, Zajarias A, Piana R, Melby S, Coylewright M, Vatterott A, Stassi K, Novak E and Lindman B (2017). Depression as a Potential Therapeutic Target to Improve Quality of Life After Transcatheter Aoritc Valve Replacement [Abstract].

    Other

    1. Mahmud E, Dauerman HL, Welt FGP, Messenger JC, Rao SV, Grines C, Mattu A, Kirtane AJ, Jauhar R, Meraj P, Rokos IC, Rumsfeld JS, Henry TD (2020). Management of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Statement From the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP). J Am Coll Cardiol (76(11), pp. 1375-1384). United States. (Read full article)
    2. Shah PB, Welt FGP, Mahmud E, Phillips A, Kleiman NS, Young MN, Sherwood M, Batchelor W, Wang DD, Davidson L, Wyman J, Kadavath S, Szerlip M, Hermiller J, Fullerton D, Anwaruddin S, American College of Cardiology and the Society for Cardiovascular Angiography and Interventions (2020). Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic: An ACC/SCAI Position Statement. JACC Cardiovasc Interv (13(12), pp. 1484-1488). United States. (Read full article)
  • News & Podcasts